nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activation of fibroblastic reticular cells in kidney lymph node during crescentic glomerulonephritis
|
Kasinath, Vivek |
|
|
95 |
2 |
p. 310-320 |
artikel |
2 |
A distinct bone phenotype in ADPKD patients with end-stage renal disease
|
Evenepoel, Pieter |
|
|
95 |
2 |
p. 412-419 |
artikel |
3 |
Bankir L, Yang B. New insights into urea and glucose handling by the kidney, and the urine concentrating mechanism. Kidney Int. 2012;81:1179–1198
|
|
|
|
95 |
2 |
p. 469 |
artikel |
4 |
Brugada phenocopy induced by hyperkalemia
|
Zhuo, Min |
|
|
95 |
2 |
p. 471 |
artikel |
5 |
Burden, access, and disparities in kidney disease
|
Crews, Deidra C. |
|
|
95 |
2 |
p. 242-248 |
artikel |
6 |
Editorial Board
|
|
|
|
95 |
2 |
p. A1 |
artikel |
7 |
Generation of renal Epo-producing cell lines by conditional gene tagging reveals rapid HIF-2 driven Epo kinetics, cell autonomous feedback regulation, and a telocyte phenotype
|
Imeri, Faik |
|
|
95 |
2 |
p. 375-387 |
artikel |
8 |
HIF-1α inducing exosomal microRNA-23a expression mediates the cross-talk between tubular epithelial cells and macrophages in tubulointerstitial inflammation
|
Li, Zuo-Lin |
|
|
95 |
2 |
p. 388-404 |
artikel |
9 |
Improved outcomes for kidney transplantation in AL amyloidosis: impact on practice
|
Nuvolone, Mario |
|
|
95 |
2 |
p. 258-260 |
artikel |
10 |
In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection
|
Yagisawa, Takafumi |
|
|
95 |
2 |
p. 350-362 |
artikel |
11 |
In this issue
|
|
|
|
95 |
2 |
p. 241 |
artikel |
12 |
Journal Club
|
|
|
|
95 |
2 |
p. 249-251 |
artikel |
13 |
Kidney transplantation from donors after uncontrolled circulatory death: the Spanish experience
|
del Río, Francisco |
|
|
95 |
2 |
p. 420-428 |
artikel |
14 |
Knockout of TRPC6 promotes insulin resistance and exacerbates glomerular injury in Akita mice
|
Wang, Liming |
|
|
95 |
2 |
p. 321-332 |
artikel |
15 |
Long-term outcome of kidney transplantation in AL amyloidosis
|
Angel-Korman, Avital |
|
|
95 |
2 |
p. 405-411 |
artikel |
16 |
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
|
Floege, Jürgen |
|
|
95 |
2 |
p. 268-280 |
artikel |
17 |
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
|
Rovin, Brad H. |
|
|
95 |
2 |
p. 281-295 |
artikel |
18 |
mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases
|
Johnson, Simon C. |
|
|
95 |
2 |
p. 455-466 |
artikel |
19 |
New pathogenic insights inform therapeutic target development for renal osteodystrophy
|
Hruska, Keith A. |
|
|
95 |
2 |
p. 261-263 |
artikel |
20 |
Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies
|
Bobart, Shane A. |
|
|
95 |
2 |
p. 429-438 |
artikel |
21 |
Paradoxically normal location of peritoneal dialysis catheter
|
Tanasiychuk, Tatiana |
|
|
95 |
2 |
p. 470 |
artikel |
22 |
Plasma endostatin predicts kidney outcomes in patients with type 2 diabetes
|
Chauhan, Kinsuk |
|
|
95 |
2 |
p. 439-446 |
artikel |
23 |
Platelet retention in inflamed glomeruli occurs via selective prolongation of interactions with immune cells
|
Finsterbusch, Michaela |
|
|
95 |
2 |
p. 363-374 |
artikel |
24 |
Proliferative glomerulonephritis with monoclonal Ig deposits (PGNMID): diagnostic and treatment challenges for the nephrologist!
|
Kousios, Andreas |
|
|
95 |
2 |
p. 467-468 |
artikel |
25 |
Regulatory roles of hypoxia-inducible, noncoding RNAs on mitochondrial dynamics during AKI
|
Tanaka, Tetsuhiro |
|
|
95 |
2 |
p. 252-253 |
artikel |
26 |
Reimagining the kidney biopsy in the era of diagnostic biomarkers of glomerular disease
|
Rovin, Brad H. |
|
|
95 |
2 |
p. 265-267 |
artikel |
27 |
Sodium and water handling during hemodialysis: new pathophysiologic insights and management approaches for improving outcomes in end-stage kidney disease
|
Canaud, Bernard |
|
|
95 |
2 |
p. 296-309 |
artikel |
28 |
Subscription Information
|
|
|
|
95 |
2 |
p. A3 |
artikel |
29 |
Table of Contents
|
|
|
|
95 |
2 |
p. A5, A7, A9, A11 |
artikel |
30 |
The authors reply
|
Hogan, Jonathan J. |
|
|
95 |
2 |
p. 468 |
artikel |
31 |
The Case | A 78-year-old woman with acute kidney injury and hemolytic anemia
|
Zecher, Daniel |
|
|
95 |
2 |
p. 473-474 |
artikel |
32 |
The Fracture Risk Assessment Tool (FRAX®) predicts fracture risk in patients with chronic kidney disease
|
Whitlock, Reid H. |
|
|
95 |
2 |
p. 447-454 |
artikel |
33 |
The proteome microenvironment determines the protective effect of preconditioning in cisplatin-induced acute kidney injury
|
Späth, Martin R. |
|
|
95 |
2 |
p. 333-349 |
artikel |
34 |
The renal draining lymph nodes in acute inflammatory kidney disease
|
Kitching, A. Richard |
|
|
95 |
2 |
p. 254-256 |
artikel |
35 |
TRPC6 in diabetic kidney disease: good guy or bad guy?
|
Staruschenko, Alexander |
|
|
95 |
2 |
p. 256-258 |
artikel |
36 |
Uncontrolled DCD donation—tilting at windmills or pushing against an open door?
|
Summers, Dominic M. |
|
|
95 |
2 |
p. 263-265 |
artikel |